Evidence map›Paper›PMID 42432364›Full record

ReviewNature immunology2026

Rediscovering eosinophil identity through tissue adaptation.

Svetoslav Chakarov, Heping Xu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Svetoslav ChakarovShanghai Institute of Immunology, Department of Immunology and Microbiology, and Center for Human Translational Immunology Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. svetoslav_chakarov@shsmu.edu.cn.ORCID http://orcid.org/0000-0002-0665-5417
Heping XuState Key Laboratory of Gene Expression, School of Medicine and School of Life Sciences, Westlake University, Hangzhou, China. xuheping@westlake.edu.cn.ORCID http://orcid.org/0000-0003-2149-7004

Funding

National Natural Science Foundation of China (National Science Foundation of China) 32470920National Natural Science Foundation of China (National Science Foundation of China) 82325023National Science Foundation of China | Young Scientists Fund W2532025
6 · The paper itself

Abstract

Eosinophils are now recognized as multifunctional immune cells that contribute to tissue homeostasis, repair, metabolism and host defense in addition to fulfilling their established roles in type 2 immunity and allergic disease. Substantial eosinophil heterogeneity is evident across tissues and inflammatory states, challenging the view that eosinophils are a uniform population of short-lived effector granulocytes. Here we discuss the current understanding of eosinophil development, tissue adaptation and functional specialization across organs and disease contexts. We propose an integrated framework in which eosinophil identity is shaped by four interdependent axes: differentiation and lineage commitment; local environmental cues; time of tissue residence; and inflammatory status. Together, these factors generate eosinophil states that are dynamic, context dependent and continuously tuned to their tissue environment. Viewing eosinophils through this multidimensional lens reframes these cells as adaptable participants in tissue physiology, rather than solely as terminal effectors of type 2 immunity.

Indexed as

Adaptation, PhysiologicalEosinophilsAnimalsCell DifferentiationCell LineageHomeostasisHumansInflammation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.